Validation of correction factors for serum markers for first-trimester down syndrome screening in singleton pregnancies conceived with assisted reproduction

Fetal Diagnosis and Therapy

Volumn 34, Issue 4, 2013, Pages 217-224

  Engels, Melanie A J ^a   Pajkrt, Eva ^b   Groot, Dominique T ^a   Schats, Roel ^a   Twisk, Jos W R ^a   Van Vugt, John M G ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Assisted reproduction; Down syndrome; First trimester screening; Free hCG; PAPP A

Indexed keywords

CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; EMBRYO TRANSFER; FALSE POSITIVE RESULT; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HORMONAL THERAPY; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; FERTILIZATION IN VITRO; HUMANS; NETHERLANDS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84890123054     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000355527     Document Type: Article

References (41)

1. Health Council of the Netherlands: Prenatal Screening (2); Down's syndrome, neural tube defects. The Hague: Health Council of the Netherlands, 2004; publication no. 2004/06 (in Dutch).
2. De Graaf IM, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, van Lith JM: Co-variables in first trimester maternal serum screening. Prenat Diagn 2000; 20: 186-189.
3. Schmidt L, Sobotka T, Bentzen JG, Nyboe Andersen A; ESHRE Reproduction and Society Task Force: Demographic and medical consequences of the postponement of parenthood. Hum Reprod Update 2012; 18: 29-43.
4. Johnson JA, Tough S; Society of Obstetricians and Gynaecologists of Canada: Delayed childbearing. J Obstet Gynaecol Can 2012; 34: 80-93.
5. Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H: Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 1996; 16: 1111-1114.
6. Ribbert LS, Kornman LH, De Wolf BT, Simons AH, Jansen CA, Beekhuis JR, Mantingh A: Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 1996; 16: 35-38.
7. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN: Serum triplemarker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 1997; 90: 98-101.
8. Wald NJ, White N, Morris JK, Huttly WJ, Canick JA: Serum markers for Down's syndrome in women who have had in vitro fertilization: implications for antenatal screening. Br J Obstet Gynaecol 1999; 106: 1304-1306.
9. Orlandi F, Rossi C, Allegra A, Krantz D, Hallahan T, Orlandi E, Macri J: First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 2002; 22: 718-721.
10. Ghisoni L, Ferrazzi E, Castagna C, Levi Setti PE, Masini AC, Pigni A: Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients. Placenta 2003; 24(suppl B):S99-S103.
11. Lambert-Messerlian G, Dugoff L, Vidaver J, Canick JA, Malone FD, Ball RH, Comstock CH, Nyberg DA, Saade G, Eddleman K, Klugman S, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Alton MED: First-and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Prenat Diagn 2006; 26: 672-678.
12. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH: First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16: 1501-1504.
13. Amor DJ, Xu JX, Halliday JL, Francis I, Healy DL, Breheny S, Baker HWG, Jaques AM: Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first-trimester screening for Down syndrome. Hum Reprod 2009; 24: 1330-1338.
14. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A: First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol 2009a;33: 8-17.
15. Engels MAJ, Kooij M, Schats R, Twisk JWR, Blankenstein MA, Van Vugt JMG: First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction. Prenat Diagn 2010; 30: 372-377.
16. Tul N, Novak-Antolic Z: Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn 2006; 26: 1206-1211.
17. Maymon R, Shulman A: Integrated first-and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 2004; 24: 125-129.
18. Wojdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A: First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 2001; 21: 563-565.
19. Bellver J, Lara C, Soares SR, Ramirez A, Pellicer A, Remohi J, Serra V: First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 2005; 20: 2623-2627.
20. Matilainen R, Peuhkurinen S, Laitinen P, Jarvela I, Morin-Papunen L, Ryynanen M: In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceives after assisted reproduction compared to spontaneous pregnancies. Fertil Steril 2011; 95: 378-381.
21. Anckaert E, Schiettecatte LT, Sleurs E, Devroey P, Smitz J: First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotrophin levels at 10-14 weeks of gestation. Fertil Steril 2008; 90: 1208-1210.
22. Niemimaa M, Heinonen S, Seppala M, Hippelainen M, Martikainen H, Ryynanen M: First-trimester screening for Down's syndrome in in vitro fertilization pregnancies. 2ertil Steril 2001; 76: 1282-1283.
23. Bersinger NA, Wunder D, Vanderlick F, Chanson A, Pescia G, Janecek P, Boillat E, Birkhauser MH: Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening. Prenat Diagn 2004; 24: 471-477.
24. Bender F, Hecken J, Reinsberg J, Berg C, van de Gembruch U, Geipel A: Altered fisrt-trimester screneing markers after IVF/ICSI: no relationship with small-for-gestational-age and number of embryos transferred. Reprod Biomed Online 2010; 20: 516-522.
25. Hui PW, Lam YH, Tang MH, NG EH, Yeung WS, Ho PC: Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn 2005a;25: 390-393.
26. Cowans NJ, Spencer K: Effect of gestational age on first trimester maternal serum prenatal screening correction factors for ethnicity and IVF conception. Prenat Diagn 2013; 33: 56-60.
27. Bettio D, Venci A, Levi Setti PE: Chromosomal abnormalities in miscarriages after different assisted reproduction procedures. Placenta 2008; 29(suppl B):126-128.
28. Koulischer L, Verloes A, Lesenfants S, Jamar M, Herens C: Genetic risk in natural and medically assisted procreation. Early Pregnancy 1997; 3: 164-171.
29. Aboulgar H, Aboulghar M, Mansour R, Serour G, Amin Y, Al-Inany H: A prospective controlled study of karyotyping for 430 consecutive babies conceived through intracytoplasmic sperm injection. Fertil Steril 2001; 76: 249-253.
30. Bonduelle M, Van Assche E, Joris H, Keymolen K, Devroey P, Van Steirteghem A, Liebaers I: Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 2002; 17: 2600-2614.
31. Allen VM, Wilson RD, Cheung A: Pregnancies outcomes after assisted reproductive techniques. J Obstet Gynaecol Can 2006; 28: 220-250.
32. Roseboom TJ, Vermeiden JP, Schoute E, Lens JW, Schats R: The probability of pregnancy after embryo transfer is affected by the age of the patient, cause of infertility, number of embryos transferred and the average morphology score, as revealed by multiple logistic regression analysis. Hum Reprod 1995; 10: 3035-3041.
33. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346.
34. Go AT, Hupkes HW, Lomecky M, Twisk J, Blankenstein JM, van Vugt JM: [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy]. Ned Tijdschr Geneeskd 2005; 149: 2795-2799.
35. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH: First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000; 107: 1265-1270.
36. Santolaya-Forgas J, De Leon JA, Cullen Hopkins R, Castracante VD, Kauffman RP, Sifuentes GA: Low pregnancy-associated plasma protein-A at 10 + 1 to 14 + 6 weeks of gestation and a possible mechanism leading to miscarriage. Fetal Diagn Ther 2004; 19: 456-461.
37. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH: Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005; 106: 260-267.
38. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM: Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762-1767.
39. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH: First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 2008; 31: 147-152.
40. Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Desilets VA, Johnson JA, Langlois S, Summers A, Wyatt P: Society of Obstetricians and Gynaecologists of Canada Genetics Committee. Obstetrical complications associated with maternal serum markers analytes. J Obstet Gynecol Can 2008; 30: 948-949.
41. Fracheboud J, Van Agt HME, De Koning HJ: 2011. [Monitoring 2009 screeningsprogramma Downsyndroom/Structureel Echoscopisch Onderzoek]. www.rivm.nl.